Atlas Trials

Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer

Clinical trial NCT00401128 · COMPLETED

Trial details

NCT number
NCT00401128
Sponsor
The Cleveland Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Kidney Cancer
Start date
2004-05-01
Primary completion
2007-02-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.